• Episode 62: To Zepbound or Not to Zepbound, that is the question!

  • 2025/04/18
  • 再生時間： 38 分
  • ポッドキャスト

Episode 62: To Zepbound or Not to Zepbound, that is the question!

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this episode of the Pound of Cure Weight Loss Podcast, hosts Matthew Weiner, MD, and Zoë engage in a Q&A session addressing listener-submitted questions. They discuss various topics including the importance of dietary choices post-bariatric surgery, the implications of protein shake consumption, the recurrence of hiatal hernias after gastric bypass, the role of GLP-1 medications in weight management, and the differences between type 1 and type 2 diabetes. The conversation emphasizes the need for personalized care and long-term support in weight loss and health management. In this conversation, Dr. Matthew Weiner discusses the impact of GLP-1 medications on diabetes management, particularly focusing on their role in weight loss and insulin sensitivity. He explains the complexities of treating type 1 and type 2 diabetes and introduces the Platinum Program designed to streamline patient care and reduce costs. The discussion also touches on the integration of AI in diabetes management tools and the challenges faced in enhancing these technologies.

    Learn more about our Platinum Program here!
    続きを読む 一部表示

あらすじ・解説

In this episode of the Pound of Cure Weight Loss Podcast, hosts Matthew Weiner, MD, and Zoë engage in a Q&A session addressing listener-submitted questions. They discuss various topics including the importance of dietary choices post-bariatric surgery, the implications of protein shake consumption, the recurrence of hiatal hernias after gastric bypass, the role of GLP-1 medications in weight management, and the differences between type 1 and type 2 diabetes. The conversation emphasizes the need for personalized care and long-term support in weight loss and health management. In this conversation, Dr. Matthew Weiner discusses the impact of GLP-1 medications on diabetes management, particularly focusing on their role in weight loss and insulin sensitivity. He explains the complexities of treating type 1 and type 2 diabetes and introduces the Platinum Program designed to streamline patient care and reduce costs. The discussion also touches on the integration of AI in diabetes management tools and the challenges faced in enhancing these technologies.

Learn more about our Platinum Program here!
続きを読む 一部表示

Episode 62: To Zepbound or Not to Zepbound, that is the question!に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。